- October 03, 2024Source: Yale Daily News
Yale mental health experts weigh in on increasing national suicide rates
- October 02, 2024
Bipolar Disorder Patients Respond to Ketamine, Esketamine Treatment
- August 20, 2024Source: The Wall Street Journal
People Are Injecting Ketamine at Home
- May 23, 2024Source: Psychology Today
Psychedelics: Subjectivity in the Therapeutic Response
- May 02, 2024Source: The New England Journal of Medicine
Depression — Understanding, Identifying, and Diagnosing
- April 03, 2024Source: Psychology Today
What I Want My Patients to Know: Ketamine for Depression
Yale Depression Research Program
Operated jointly by the Yale University School of Medicine Department of Psychiatry and Connecticut Mental Health Center, the Yale Depression Research Program has, for over 30 years, been committed to advancing the treatment of depression. By engaging in studies that seek to elucidate the underlying neurobiology of depression, we are striving to improve our ability to diagnose and treat mood disorders.
From the Medical Director
Depression remains one of the most common and debilitating medical problems throughout the world. At the Yale Depression Research Program, we are committed to advancing our ability to understand, diagnose, and treat depression through innovative research.